|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income | ||
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Change in fair value of warrant liabilities | ||
| Interest earned on marketable securities held in Trust Account | ||
| Unrealized gain (loss) on marketable securities held in Trust Account | ||
| Offering costs charged directly to operations | ||
| Transaction costs associated with the Initial Public Offering | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Prepaid income taxes | ||
| Non-current prepaid insurance | ||
| Accrued expenses | ||
| Deferred tax liability | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash into Trust Account | ||
| Cash withdrawn from Trust Account to pay franchise and income taxes | ||
| Net cash provided by (used in) investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from sale of Units, net of underwriting discount paid | ||
| Proceeds from sale of Private Placement Units | ||
| Advances from related party | ||
| Repayment of promissory note – related party | ||
| Payment of offering costs | ||
| Net cash provided by financing activities | ||
| Net Change in Cash | ||
| Cash – Beginning of period | ||
| Cash – End of period | ||
| Supplementary cash flow information: | ||
| Cash paid for income taxes | ||
| Non-Cash investing and financing activities: | ||
| Excess payment of filing fees charged directly to operations | ||
| Accretion of Class A common stock to redemption value | ||
| Deferred underwriting fee payable |
Loading...
